Tag: ESMINT 2022
Women in Neurointervention: How do we boost representation within “male-dominated” field?
Female representation in the neurointerventional world may be growing, but Johanna Fifi (Mount Sinai, New York, USA) and Anne-Christine Januel (Toulouse University Hospital, Toulouse,...
A closer look at the GECKO system following first-in-human study results
Following the presentation of first-in-human cases with the GECKO system at the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September,...
Education and awareness paramount in moving eastern European stroke care forward
The urgent need for more comprehensive, standardised thrombectomy services is starting to be recognised and acted upon across Western Europe, but—as discussions at this...
Process times and regional variation are main areas of concern for...
Technical and clinical outcomes associated with mechanical thrombectomy treatments in England are currently “acceptable”, but ‘drip-and-ship’ patients, process times and variation between units all...
Physicians should prioritise first-pass optimisation over speed in thrombectomy procedures
Achieving clot retrieval with the fewest possible number of passes is critical in mechanical thrombectomy, and may even hold greater importance than how quickly...
Wallaby/phenox officially announces global launch of Pegasus HPC stent system
Wallaby/phenox has officially announced the successful global launch of its novel Pegasus hydrophilic polymer coating (HPC) stent, having first unveiled the device at the 2022...
Similar complication rates observed following DAPT discontinuation within and past 90...
The duration of dual antiplatelet therapy (DAPT), either 30–90 days or more than 90 days, following implantation of a flow diverter in cerebral aneurysm...
Adjunctive therapy demonstrates comparable aneurysm occlusion rates to established flow diverters
The Neqstent coil-assisted flow diverter (Cerus Endovascular) has demonstrated comparable occlusion rates to those seen with other, similar flow diversion technologies, as well as...
CorPath GRX robot demonstrates safety and effectiveness in neurovascular aneurysm treatment
Corindus, a Siemens Healthineers company, announced today the recent presentation of results from a “first-of-its-kind” study demonstrating the safety and effectiveness of robotic-assisted neurovascular...
Basecamp Vascular announces first-in-human cases with steerable mechatronic guidewire
Basecamp Vascular (BCV) has announced a “major step” in the development and evaluation of steerable mechatronic guidewires for stroke treatment via its GECKO system....
New-look ESMINT congress to reflect on ISAT study and prioritise international...
After a long period of uncertainty triggered by a worldwide pandemic, the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September,...
